When NDAT combines with resveratrol in CRC treatment, NDAT reduces the expression of ribonucleotide reductase regulatory subunit M2 (RRM2) induced by the stilbene and potentiates resveratrol-induced anticancer activity [24]. This evidence concerns the gene RRM2 and colorectal carcinoma.